According to previous cases of NSCLC harboring an EGFR mutation with choroidal metastasis treated with EGFR-TKI as a first-line treatment [4-14], ocular symptoms can improve with EGFR-TKI in most cases, although some reports do not provide details of the therapeutic effects. Here, EGFR is linked to non-small cell lung carcinoma.